HALISTER1: Aptose Biosciences Rises; HC Wainwright Sees Inflection Point

Aptose Biosciences Rises; HC Wainwright Sees Inflection Point

(Bloomberg) -- Aptose Biosciences rises 8% pre-market on 2.6k volume after HC Wainwright upgraded to buy from neutral, PT $4 from $1.
  • Says co. made progress on the manufacturing process for CG’806 and is targeting the initiation of toxicology studies shortly
  • Says an IND filing is targeted for 1H 2018, assuming clean toxicology studies, with the initiation of the clinical programs soon after that
  • Notes the Ash conf. in December should provide more visibility on CG’806
  • NOTE: Jan. 23, Aptose Pauses APTO-253 Development, Will Prioritize CG’806
To contact the reporter on this story: Tatiana Darie in New York at tdarie1@bloomberg.net To contact the editors responsible for this story: Arie Shapira at ashapira3@bloomberg.net Steven Fromm

Alert: HALISTER1
Source: BFW (Bloomberg First Word)

Tickers
APS CN (Aptose Biosciences Inc)

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283

HALISTER1: Latitude Australia Credit Card Loan Note Trust – Series 2017-2 - DBRS Rating Report

Latitude Australia Credit Card Loan Note Trust – Series 2017-2 - DBRS Rating Report

Alert: HALISTER1
Source: DBR (Dominion Bond Rating Service)

People
Alexander Garrod (Dbrs Europe Ltd)
Kevin Chiang (DBRS Ltd)

Topics
Fixed Income Research
Credit Research
Reports
Credit Analysis Research
Investment Research

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283

HALISTER1: BNP Says Time to Switch to Bumi From Indika for More Bond Upside

BNP Says Time to Switch to Bumi From Indika for More Bond Upside

(Bloomberg) -- Investors should switch into notes issued by Indonesian coal miner Bumi Resources for bigger gains as the rally in Indika Energy bonds cools, according to BNP Paribas.
  • “Bumi is our top pick in the Indonesian coal sector,” the French bank says in a note Thursday. “The settlement deadline for the restructured Bumi bonds has been extended until Sept. 11, so the instruments would be free to trade from Sept. 12 onwards”
    • NOTE: Bumi Resources Starts Debt Exchange in Restructuring Plan
    • NOTE: Bumi Sees 2017 Profit at $350m on Higher Coal Price, Debt Recast
  • Indika Energy’s 2023s have performed well since the bank started covering them when they were trading ~50 cents on the dollar due to coal price rebound and the co.’s refinancing efforts: BNP
  • While the notes still offer “good carry” through the winter, there is little price upside seen with 2022s yielding 6.4% and 2023s at 6.7%
    • Risk for the bonds may be more supply in sector as “we hear few new Indonesian coal company mandates could price in the coming weeks”
    • Indika unlikely to benefit more from coal price increases this yr as only a small proportion of its coal contracts are pegged to benchmark spot price
  • NOTE: Coal at Newcastle port +1.6% to $96.20 ytd; +87% in 2016
To contact the reporter on this story: David Yong in Singapore at dyong@bloomberg.net To contact the editors responsible for this story: Neha D'silva at ndsilva1@bloomberg.net Chan Tien Hin

Alert: HALISTER1
Source: BFW (Bloomberg First Word)

Tickers
BUMI IJ (Bumi Resources Tbk PT)
INDY IJ (Indika Energy Tbk PT)

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283

HALISTER1: Towards a Harmonised Covered Bond Instrument – Extend but Don’t Pretend - DBRS Commentary

Towards a Harmonised Covered Bond Instrument – Extend but Don’t Pretend - DBRS Commentary

Alert: HALISTER1
Source: DBR (Dominion Bond Rating Service)

People
Christian Aufsatz (DBRS Inc)
Gordon Kerr (Dbrs Europe Ltd)

Topics
Fixed Income Research
Credit Analysis Research
Credit Research
Investment Research

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283